GENENTECH
Lobbying client. Federal LDA filings.
Connected on the graph
Inbound (18)
| date | from | type | amount | role | source |
|---|---|---|---|---|---|
| — | Cynthia Brown | lobbied_for | — | lda_lobbyist_client | |
| — | Jeffrey Forbes | lobbied_for | — | lda_lobbyist_client | |
| — | Kristina Dunklin | lobbied_for | — | lda_lobbyist_client | |
| — | Zachary Williams | lobbied_for | — | lda_lobbyist_client | |
| — | Michael Alexander Williams | lobbied_for | — | lda_lobbyist_client | |
| — | Ashley Palmer | lobbied_for | — | lda_lobbyist_client | |
| — | Elizabeth Greer | lobbied_for | — | lda_lobbyist_client | |
| — | Erik Fatemi | lobbied_for | — | lda_lobbyist_client | |
| — | Dianne Nellor | lobbied_for | — | lda_lobbyist_client | |
| — | Barrett Thornhill | lobbied_for | — | lda_lobbyist_client | |
| — | Jerry Driscoll | lobbied_for | — | lda_lobbyist_client | |
| — | Monica Popp | lobbied_for | — | lda_lobbyist_client | |
| — | Derrick M White | lobbied_for | — | lda_lobbyist_client | |
| — | Hazen Clay Marshall | lobbied_for | — | lda_lobbyist_client | |
| 2026-01-01 | CORNERSTONE GOVERNMENT AFFAIRS, INC. | lobbies_for | $50,000 | lda_filing | |
| 2026-01-01 | TIBER CREEK HEALTH STRATEGIES, INC. | lobbies_for | $60,000 | lda_filing | |
| 2026-01-01 | FORBES-TATE | lobbies_for | $50,000 | lda_filing | |
| 2026-01-01 | MARSHALL & POPP, LLC | lobbies_for | $60,000 | lda_filing |
Outbound (4)
| date | type | to | amount | role | source |
|---|---|---|---|---|---|
| 2026-01-01 | lobbies_on_bill | HR 1492 — To amend title XI of the Social Security Act to equalize the negotiation period between sm | — | H.R. 1492 | lobbying_bill_mention |
| 2026-01-01 | lobbies_on_bill | HR 7148 — Consolidated Appropriations Act, 2026 | — | H.R.7148 | lobbying_bill_mention |
| 2026-01-01 | lobbies_on_bill | S 1040 — Drug Competition Enhancement Act | — | S.1040 | lobbying_bill_mention |
| 2026-01-01 | lobbies_on_bill | S 1041 — Affordable Prescriptions for Patients Act | — | S.1041 | lobbying_bill_mention |
- Source id
196554- General description
- A biotechnology corporation
- State
- CA
- Country
- US
- Principal place of business
- US
- Government-entity client
- false
- Effective date
- 2013-07-01
- Total spend (across 1 ingested filings)
- $50,000
Filings
| Posted | Type | Year | Lobbying firm | Income |
|---|---|---|---|---|
| 2026-04-18 | Q1 | 2026 | FORBES-TATE | $50,000 |